申请人:Camus Laure
公开号:US20080306045A1
公开(公告)日:2008-12-11
The invention relates to chemical entities of formula (I):
and/or pharmaceutically acceptable derivative(s) thereof. The invention also relates to processes for the preparation of compounds of formula (I), pharmaceutical compositions containing compounds of formula (I) and to the use of compounds of formula (I) in medicine, particularly in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
该发明涉及式(I)的化学实体和/或其药用可接受衍生物。该发明还涉及制备式(I)化合物的方法,含有式(I)化合物的药物组合物以及在医学中使用式(I)化合物,特别是在改善适用于Xa因子抑制剂的临床病况中的使用。